Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices
- PMID: 25769512
- DOI: 10.1016/j.hrthm.2015.03.011
Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices
Abstract
Background: Left atrial appendage (LAA) closure devices have been introduced recently as an alternative for oral anticoagulation (OAC) in patients with nonvalvular atrial fibrillation (AF). Because of potential overlap of ablation target areas and the previously implanted LAA closure device, as well as potential complications such as mechanical damage to the device, left atrial (LA) ablation remains a subject of debate in these patients.
Objective: We report on the feasibility and clinical efficacy of LA ablation after implantation of LAA closure devices.
Methods: Eight patients (6 men; age 69 ± 8 years) with symptomatic paroxysmal AF (n = 5) or persistent AF (mean CHA2DS2-VASc score 3.6 ± 0.7, mean HAS-BLED score 3.6 ± 1.5) and previously implanted WATCHMAN (7 patients) or AMPLATZER Cardiac Plug (1 patient) LAA closure devices received radiofrequency-based LA ablation (4 via circumferential pulmonary vein isolation [CPVI], 4 via CPVI and additional LA linear lesions or complex fractionated atrial electrograms) after a mean of 201 days (range 41-756 days) after LAA closure.
Results: Successful LA ablation was achieved without device interference or periprocedural complications. After a mean of 503 days (range 113-1006 days), transesophageal echocardiography (TEE) was performed in all patients to assess for device-related complications. No device dislocation or leakage was observed. In 1 patient (12.5%), a device-related thrombus was found despite therapeutic OAC with dabigatran. Five patients (63%) remained in stable sinus rhythm, and no bleeding events or stroke occurred during a follow-up of 554 days (range 218-1006 days).
Conclusion: LA ablation after LAA closure appears to be feasible. Device-related thrombus formation in 1 patient suggests the need for further TEE examinations after LA ablation after LAA closure device implantation.
Keywords: Atrial fibrillation; Catheter ablation; Left atrial appendage closure; Stroke prevention.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Comment in
-
Catheter ablation for atrial fibrillation in patients with left atrial appendage closure devices.Heart Rhythm. 2015 Jul;12(7):1532-3. doi: 10.1016/j.hrthm.2015.03.040. Epub 2015 Mar 23. Heart Rhythm. 2015. PMID: 25814416 No abstract available.
Similar articles
-
Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.Europace. 2015 Oct;17(10):1533-40. doi: 10.1093/europace/euv070. Epub 2015 May 1. Europace. 2015. PMID: 25935163
-
Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.Heart Rhythm. 2013 Dec;10(12):1792-9. doi: 10.1016/j.hrthm.2013.08.025. Epub 2013 Aug 22. Heart Rhythm. 2013. PMID: 23973952 Clinical Trial.
-
Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.Europace. 2019 Mar 1;21(3):428-433. doi: 10.1093/europace/euy237. Europace. 2019. PMID: 30380015
-
The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):100-3. doi: 10.14797/mdcj-11-2-100. Methodist Debakey Cardiovasc J. 2015. PMID: 26306127 Free PMC article. Review.
-
Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.Expert Rev Med Devices. 2009 Nov;6(6):611-20. doi: 10.1586/erd.09.45. Expert Rev Med Devices. 2009. PMID: 19911873 Review.
Cited by
-
[Electrical isolation of the left atrial appendage : Benefits and risks].Herz. 2017 Jun;42(4):364-372. doi: 10.1007/s00059-017-4559-0. Herz. 2017. PMID: 28357448 Review. German.
-
Insufficient Ablation is Associated with Atrial Fibrillation Recurrence after Combining Ablation and Left Atrial Appendage Closure.Rev Cardiovasc Med. 2024 Jan 9;25(1):10. doi: 10.31083/j.rcm2501010. eCollection 2024 Jan. Rev Cardiovasc Med. 2024. PMID: 39077666 Free PMC article.
-
Safety and feasibility of pulmonary vein isolation utilizing pulsed field ablation in patients with symptomatic atrial fibrillation and implanted Watchman devices.J Interv Card Electrophysiol. 2024 Nov;67(8):1727-1734. doi: 10.1007/s10840-024-01876-x. Epub 2024 Jul 15. J Interv Card Electrophysiol. 2024. PMID: 39007968
-
Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single-center experience of the left atrial appendage closure first strategy.J Arrhythm. 2024 May 23;40(4):879-890. doi: 10.1002/joa3.13073. eCollection 2024 Aug. J Arrhythm. 2024. PMID: 39139871 Free PMC article.
-
Cryoballoon pulmonary vein isolation and voltage mapping for symptomatic atrial fibrillation 9 months after Watchman device implantation.HeartRhythm Case Rep. 2017 Oct 25;4(1):6-9. doi: 10.1016/j.hrcr.2017.10.004. eCollection 2018 Jan. HeartRhythm Case Rep. 2017. PMID: 29379717 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical